CLVT stock icon

Clarivate
CLVT

$7.03
1.88%

Market Cap: 4.7B

 

About: Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Employees: 12,000

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 5 analysts
0
News positive %
of 11 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

4.35% less ownership

Funds ownership: 89.61% [Q4 2023] → 85.26% (-4.35%) [Q1 2024]

7% less funds holding

Funds holding: 214 [Q4 2023] → 199 (-15) [Q1 2024]

10% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 78

17% less funds holding in top 10

Funds holding in top 10: 12 [Q4 2023] → 10 (-2) [Q1 2024]

23% less capital invested

Capital invested by funds: $5.51B [Q4 2023] → $4.22B (-$1.29B) [Q1 2024]

32% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 47

50% less call options, than puts

Call options by funds: $307K | Put options by funds: $619K

Research analyst outlook

5 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$6
15%
downside
Avg. target
$7.90
12%
upside
High target
$10
42%
upside

5 analyst ratings

positive
40%
neutral
40%
negative
20%
Goldman Sachs
George Tong
7%upside
$7.5
Buy
Maintained
9 May 2024
Morgan Stanley
Toni Kaplan
14%upside
$8
Equal-Weight
Maintained
28 Feb 2024
Barclays
Manav Patnaik
15%downside
$6
Underweight
Maintained
28 Feb 2024
RBC Capital
Ashish Sabadra
14%upside
$8
Sector Perform
Maintained
28 Feb 2024
Oppenheimer
Owen Lau
42%upside
$10
Outperform
Maintained
28 Feb 2024

Financial journalist opinion

Based on 11 articles about CLVT published over the past 30 days